Therefore, the results confirmed that the SPHK inhibitor (ABC294640) and ZA could inhibit the expression of OC-specific factors during OC differentiation in the APL microenvironment in vitro. This evidence concerns the gene SPHK1 and acute promyelocytic leukemia.